Adding Neurocognitive Component to Balance Test (NCT06827483) | Clinical Trial Compass
By InvitationNot Applicable
Adding Neurocognitive Component to Balance Test
United States40 participantsStarted 2025-03-14
Plain-language summary
By introducing BlazePods as a neurocognitive addition to the YBT, this study aims to determine whether this addition impacts balance performance and/or reach distances between the operative and non-operative limbs of patients recovering from ACL reconstruction. Findings will contribute to optimizing return-to-sport protocols and enhancing late-stage rehabilitation program designs.
Who can participate
Age range
18 Years – 25 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* All participants: 18-25 years old
* All participants: MARX activity questionnaire of greater than 10
* All participants: able to follow verbal instructions
* For patient participants: ACL Repair or Reconstruction within past 5-7 months
Exclusion Criteria:
* Healthy participants: Chronic Ankle Instability
* Healthy participants: Prior lower extremity surgery
* Healthy participants: LE injury \<6 months ago
* Healthy participants: current LE pain
* Healthy participants: visual deficits
* Healthy participants: vestibular or neurological deficits affecting balance
* Healthy participants: unable to maintain single leg stance for 10 seconds
* Healthy participants: unable to read or speak English
* For patient participants: Chronic Ankle Instability
* For patient participants: current LE pain
* For patient participants: multi-ligament procedure
* For patient participants: prior surgery on uninvolved limb
* For patient participants: visual deficits
* For patient participants: vestibular or neurological deficits affecting balance
* For patient participants: unable to read or speak English
* For patient participants: unable to maintain single leg stance for 10 seconds
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Y-Balance Test - reach distance with and without neurocognitive component
Timeframe: Day 1
2
Y-Balance Test - composite score with and without neurocognitive component